Earth Science Tech Inc. (OTCQB: ETST), a strategic holding company with operations spanning healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is betting on artificial intelligence and internal technological development to fuel sustainable growth and long-term value. The company’s dedicated IT infrastructure department, led by Chief Technology Officer Chris Rose, has been instrumental in leveraging new technologies to reduce costs, enhance operational efficiencies, and widen profit margins across its pharmacy and telemedicine platforms.
During the recent Annual Meeting of Shareholders, Rose outlined the company’s technology stack and the developments that have enabled ETST to offer its in-house tools to other clinics as a white-label service—a move that could open new revenue streams and strengthen its competitive position in the healthcare technology space. The strategy centers on building proprietary solutions rather than purchasing off-the-shelf software, supported by advancements in and the company’s leverage of AI.
“We build now instead of buy, supported by advancements in and our leverage of AI. We’ve built our own ETST-wide software and data platform that ties together the three pharmacies, our curative telehealth business, and My Online Consultation doctor’s [platform],” Rose said. This integrated platform allows for seamless data flow and operational synergy across the company’s diverse business lines, which is expected to drive efficiency gains and improve patient and customer experiences.
ETST also utilizes technology in its marketing efforts to increase patient and customer retention and foster brand loyalty. By analyzing data and automating outreach, the company aims to deepen relationships with its user base and maximize lifetime value. These efforts are part of a broader push to ensure that technology is not just a support function but a core driver of growth and profitability.
The implications of ETST’s technology-first approach extend beyond internal operations. By offering its tools as a white-label service, the company can potentially tap into a new market of clinics seeking affordable, integrated software solutions. This could create a recurring revenue stream and position ETST as a technology provider in the healthcare sector, not just a holding company. For investors, the emphasis on sustainable growth through technology suggests a focus on long-term value creation rather than short-term gains.
As a strategic holding company, ETST brings together innovative businesses across multiple sectors, and its investment in IT infrastructure reflects a commitment to staying ahead of industry trends. The company’s ability to build and leverage AI-driven platforms may also serve as a differentiator in the competitive telemedicine and pharmacy markets, where efficiency and patient engagement are critical.
For those tracking ETST’s progress, the latest news and updates are available in the company’s newsroom at https://ibn.fm/ETST. More detailed information about the company’s technology initiatives can be found in the full article on BioMedWire.
BioMedWire is a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. It is part of the Dynamic Brand Portfolio at IBN, which provides wire solutions through InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, and social media distribution. These services help companies like ETST reach a wide audience of investors, journalists, and consumers, amplifying their message and increasing visibility.
Investors and industry observers will be watching to see how ETST’s technology investments translate into financial performance and whether its white-label offering gains traction among clinics. If successful, the company could set a precedent for how healthcare holding companies integrate technology to drive sustainable growth.
